comparemela.com

Latest Breaking News On - Parkman healthcare partners - Page 1 : comparemela.com

Performant Financial (NASDAQ:PFMT) Stock Crosses Above Two Hundred Day Moving Average of $2.88

Performant Financial Co. (NASDAQ:PFMT – Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.88 and traded as high as $2.96. Performant Financial shares last traded at $2.92, with a volume of 49,533 shares changing hands. Analyst Upgrades and Downgrades Separately, […]

Wellington
New-zealand-general
New-zealand
United-states
Performant-financial-co
Wellington-management-group
First-light-asset-management
Parkman-healthcare-partners
Nasdaq
Performant-financial-corporation
Performant-financial-company-profile

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 11.5% in May

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 1,160,000 shares, an increase of 11.5% from the April 30th total of 1,040,000 shares. Based on an average daily trading volume, of 276,300 shares, the days-to-cover […]

United-states
America
Asia-pacific
Akoya-biosciences
Brian-mckelligon
Jpmorgan-chase-co
Nasdaq
Parkman-healthcare-partners
Asset-management-inc
Silvercrest-asset-management-group
Kent-lake-capital
Akoya-biosciences-inc

CVRx, Inc. (NASDAQ:CVRX) Receives Average Rating of "Moderate Buy" from Analysts

CVRx, Inc. (NASDAQ:CVRX – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price target among […]

William-blair
Craig-hallum
Piper-sandler
Canaccord-genuity-group
Cvrx-inc
Vanguard-group-inc
Parkman-healthcare-partners
Nasdaq
Lord-abbett
Silvercrest-asset-management-group
Johnson
Get-free-report

Silence Therapeutics (NASDAQ:SLN) Receives "Buy" Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a research note released on Friday, Benzinga reports. HC Wainwright currently has a $75.00 price objective on the stock. Several other research firms have also commented on SLN. BMO Capital Markets initiated coverage on Silence Therapeutics in a research […]

Parkman-healthcare-partners
Vivo-capital
Sg-americas-securities
Janus-henderson-group
Morgan-stanley
Silence-therapeutics
Free-report
Chardan-capital
Get-free-report
Healthcare-partners
Oligonucleotide-discovery

Silence Therapeutics (NASDAQ:SLN) Shares Down 7.4%

Silence Therapeutics (NASDAQ:SLN) Shares Down 7.4%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Silence-therapeutics-company-profile
Vivo-capital
Parkman-healthcare-partners
Redmile-group
Nasdaq
Morgan-stanley
Janus-henderson-group
Silence-therapeutics
Get-free-report
Chardan-capital
Therapeutics-stock-down

vimarsana © 2020. All Rights Reserved.